Latest filing published 13 Mar 2017 for Concert Pharmaceuticals, INC., €21k.
Insider track record
Robert Silverman: trading record in brief
Robert Silverman appears in our data through filings on Concert Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 14 filings; the first trade dates from 29 May 2014 and the latest from 9 March 2017.
Sales make up the whole of the open-market record (4 sales, €323k). Outside the open market, there are 3 share grants and 7 option exercises.
The newest entry dates from 13 March 2017: an option exercise of €12k, in Concert Pharmaceuticals, Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert Silverman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19,497 shares@ US$1.1331.5% of flowCommon StockSEC:0001209191-17-020164:0
- 1,306 shares@ US$16.8631.5% of flowCommon StockSEC:0001209191-17-020164:1
- 11,469 shares@ US$1.1318.5% of flowCommon StockSEC:0001209191-17-020164:2
- 768 shares@ US$16.8618.5% of flowCommon StockSEC:0001209191-17-020164:3
- 8,000 sharesCommon StockSEC:0001209191-16-092906:0
- 3,600 shares@ US$1.13Common StockSEC:0001209191-15-079331:0
- 185 shares@ US$21.95Common StockSEC:0001209191-15-079331:1
- 5,000 shares@ US$1.13Common StockSEC:0001209191-15-071870:0
- 5,000 shares@ US$20.00Common StockSEC:0001209191-15-071870:1
- 5,000 shares@ US$16.35Common StockSEC:0001209191-15-051829:0
- 5,000 shares@ US$1.13Common StockSEC:0001209191-15-025621:0
- 5,000 shares@ US$16.00Common StockSEC:0001209191-15-025621:1
- 20,000 shares@ US$1.13Common StockSEC:0001209191-14-038421:0
13 of 13 declarations
